ArticleJCO clinical cancer informatics2022
Future of Teleoncology: Trends and Disparities in Telehealth and Secure Message Utilization in the COVID-19 Era.
Article in JCO clinical cancer informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Virtual Care Among Adults Facing Language Barriers: A Systematic Review and Meta-Analysis.JAMA network open · 2025Pooled it
- Comparing Trends in Telemedicine Use and Geographic Disparities in Utilization Among Patients With Cancer in the United States.JCO oncology practice · 2026Article
- Reassessing the Role of Regular Physical Examination in Post-treatment Breast Cancer Surveillance.Annals of surgical oncology · 2026Article
- A scoping review of studies on secure messaging through patient portals: persistent challenges and potential solutions.npj health systems · 2026Article
- Video-based telemedicine utilization patterns and associated factors among racial and ethnic minorities in the United States during the COVID-19 pandemic: A mixed-methods scoping review.PLOS digital health · 2025Article
- Telehealth and Health Care Contact Days Among Patients With Advanced Cancer After COVID-19.JAMA network open · 2025Article
- Article
- Screening for comprehensive social needs in patients with cancer: a narrative review.JNCI cancer spectrum · 2025Review
- Disparities in telemedicine use and payment policies in the United States between 2019 and 2023.Communications medicine · 2025Article
- Telemedicine Use Among Older Adults During COVID-19: A Narrative Literature Review of Utilization Patterns.Telemedicine reports · 2025Review
- Tele-Oncology Use During the COVID-19 Pandemic: Patient Experiences and Communication Behaviors with Clinicians.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024Article
- Care Partner Engagement in Secure Messaging Between Patients With Diabetes and Their Clinicians: Cohort Study.JMIR diabetes · 2024Article
- Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022.JCO oncology practice · 2023Article
- Availability of cancer care services and the organization of care delivery at critical access hospitals.Cancer medicine · 2023Article
- The unequal burden of time toxicity.Trends in cancer · 2023Article
- Factors Associated with Telehealth Utilization among Older African Americans in South Los Angeles during the COVID-19 Pandemic.International journal of environmental research and public health · 2023Article
- Telehealth in breast cancer following the coronavirus disease 2019 pandemic.Exploration of targeted anti-tumor therapy · 2023Review
- Identifying Nonpatient Authors of Patient Portal Secure Messages in Oncology: A Proof-of-Concept Demonstration of Natural Language Processing Methods.JCO clinical cancer informatics · 2022Article
- Telehealth Adoption in an Outpatient Oncology Ward: A Best Practice Implementation Project.Nursing reports (Pavia, Italy) · 2022Article
- Telehealth Utilization During the COVID-19 Pandemic: A Preliminary Selective Review.Telemedicine reports · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe COVID-19 pandemic created an imperative to re-examine the role of telehealth in oncology. We studied trends and disparities in utilization of telehealth (video and telephone visits) and secure messaging (SM; ie, e-mail via portal/app), before and during the pandemic.
methodsRetrospective cohort study of hematology/oncology patient visits (telephone/video/office) and SM between January 1, 2019, and September 30, 2020, at Kaiser Permanente Northern California.
resultsAmong 334,666 visits and 1,161,239 SM, monthly average office visits decreased from 10,562 prepandemic to 1,769 during pandemic, telephone visits increased from 5,114 to 8,663, and video visits increased from 40 to 4,666. Monthly average SM increased from 50,788 to 64,315 since the pandemic began. Video visits were a significantly higher fraction of all visits (
conclusionIn the pandemic era, hematology/oncology telehealth and SM use rapidly increased in a manner that is feasible and sustained. Possible disparities existed in video visit and SM use by age, insurance plan, language, race, ethnicity, marital status, comorbidities, and sex.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.